BIBLIOGRAPHY, REVIEWS AND 

 GENERAL REFERENCES 



A book closely related to this one in intent and format is 

 Walter Karrer's "Konstitution und Vorkommen dcr organischen 

 Pflanzenstoffe (exclusive Alkaloide)." This lists over 2600 

 compounds with simple physical properties and thorough refer- 

 encing. The emphasis is on metabolites of higher plants, al- 

 though many fungal products are listed. 



Another related book is "Type Reactions in Fermentation 

 Chemistry," by Lowell L. Wallen, Frank H. Stodola and Rich- 

 ard W. Jackson. Here the emphasis is on non-sugar substrates, 

 and classification is by type of reaction (oxidation, reduction, 

 etc.) accomplished. Many microbial transformations of ster- 

 oids are included, for example. Structural formulas, names of 

 microorganisms and references are listed. 



The revised edition of W. W. Umbreit's "Metabolic Maps" 

 should be mentioned. This is essentially a list of equations, 

 outlining various metabolic pathways, with no discussion and 

 little referencing, but including catabolic routes and those in 

 higher organisms. 



"Naturally Occurring Quinones," by R. Thomson, is similar 

 in method to our handbook, but is confined to the single class 

 of compounds with more thorough discussion of each entry. 

 "The Comparative Biochemistry of the Carotenoids" by T. W. 

 Goodwin is somewhat similar in its restriction to a single class 

 of chemicals. Both books are broader in scope as far as pro- 

 ducing organism is concerned, and are not limited to micro- 

 organism products. 



"The Chemistry of Microorganisms," by Arthur Bracken, is 

 descriptive in style, showing some of the degradations and 

 syntheses leading to establishment of chemical structures and 

 offering essays on related topics. There is, perhaps, some 

 emphasis on substances isolated and characterized by the 

 Raistrick group. 



We have not designated antibiotics as such nor have we 

 attempted to separate the commercial from the non-commercial 

 or to give the trade names or the biological properties. Data 

 on biological properties are difficult to evaluate and, on the 

 newer antibiotics, may conflict. Trade names tend to change 

 due, for example, to improvements in dosage forms. 



